Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients

被引：0
|
作者：
Giugliano, D.
Cleall, S.
Pontiroli, A. E.
Koivisto, V.
机构：
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1037
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [21] Comparative Trial Between Combination of Glargine and Lispro Insulin Versus NPH and Regular Insulin Using a Basal/Bolus Approach in Hospitalized Patients With Type 2 Diabetes
    Puig, Alvaro
    Prieto, Luz
    Alba, Diana
    Solano, Maria P.
    DIABETES, 2012, 61 : A300 - A300
  • [22] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
    Kazda, C
    Hülstrunk, H
    Helsberg, K
    Langer, F
    Forst, T
    Hanefeld, M
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152
  • [23] Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
    Heller, Simon
    Buse, John
    Fisher, Miles
    Garg, Satish
    Marre, Michel
    Merker, Ludwig
    Renard, Eric
    Russell-Jones, David
    Philotheou, Areti
    Francisco, Ann Marie Ocampo
    Pei, Huiling
    Bode, Bruce
    LANCET, 2012, 379 (9825): : 1489 - 1497
  • [24] Efficacy and safety of insulin glulisine versus insulin lispro as part of a basal-bolus insulin regimen in children and adolescents with type I diabetes mellitus
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    DIABETOLOGIA, 2008, 51 : S382 - S382
  • [25] Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial
    Strojek, K.
    Shi, C.
    Carey, M. A.
    Jacober, S. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (10): : 916 - 922
  • [26] Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes
    Fernandez Lando, Laura
    Massari, Fabio
    Oviedo, Alejandra
    Jiang, Honghua
    MEDICINA-BUENOS AIRES, 2012, 72 (03) : 235 - 242
  • [27] Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes
    Hompesch, Marcus
    Ocheltree, Scott M.
    Wondmagegnehu, Eshetu T.
    Morrow, Linda A.
    Kollmeier, Alexa P.
    Campaigne, Barbara N.
    Jacober, Scott J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2679 - 2687
  • [28] Comparison of a multiple daily injection regimen with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: A randomised, open, parallel study
    Bolli, GB
    Capani, F
    Home, PD
    Kerr, D
    Thomas, R
    Torlone, E
    Selam, JL
    Sola-Gazagnes, A
    Vitacolonna, E
    DIABETES, 2004, 53 : A107 - A108
  • [29] Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study)
    Watada, Hirotaka
    Su, Qing
    Li, Peng Fei
    Iwamoto, Noriyuki
    Qian, Lei
    Yang, Wen Ying
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (01)
  • [30] PREMIXED INSULIN LISPRO VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES: A META-ANALYSIS
    Lili, Z.
    VALUE IN HEALTH, 2014, 17 (07) : A741 - A741
12345